GV Investment Managers

Overture Life, Inc. is a biotechnology company established in 2017 and headquartered in New York, New York. The company specializes in developing robotic technology and medical devices aimed at automating the in vitro fertilization (IVF) process. Overture Life's innovations include novel embryo testing methodologies and automated cryopreservation services, which help fertility clinics identify viable embryos prior to implantation. By streamlining the IVF process, Overture Life aims to make artificial insemination more accessible, reduce costs, optimize resource use, and improve success rates for practitioners and patients alike.

UJET, Inc. specializes in developing customer support software and platform solutions that enhance customer communications. Founded in 2015 and headquartered in San Francisco, with additional offices in New York and Seoul, the company offers a cloud contact center platform that integrates seamlessly with major customer relationship management systems like Salesforce, Zendesk, and Kustomer. UJET's platform is designed for the smartphone era, modernizing digital and in-app customer experiences while eliminating the need for customers to switch between different communication channels. By utilizing multiple voices, online messaging, and mobile features, UJET assists customer service agents in managing incoming calls and resolving issues efficiently. The incorporation of artificial intelligence across its services further automates processes and improves interaction quality. Additionally, UJET provides a wait time messaging tool that offers live updates to customers while they are on hold, enhancing overall service satisfaction.

Delphia Therapeutics operates and manages a laboratory that develops treatments for cancer cells. It studies cancer-driving pathways and their effect on creating cancer medicines. Delphia Therapeutics is based in Boston, USA.

Oula Health, Inc. specializes in maternity care services, offering both in-clinic and home-based prenatal care. Founded in 2019 and located in Brooklyn, New York, Oula aims to transform the maternity care experience by integrating obstetrics and midwifery. The company focuses on providing a personalized and evidence-based approach to pregnancy, combining modern medical practices with a compassionate understanding of human needs. Through its innovative maternity center, Oula sets a new standard for pregnancy care that emphasizes both medical expertise and personal connection.

Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease. The company was spun out of Pennsylvania-based Knopp, which published results from its phase 2 clinical trial last year that showed its oral drug candidate could reduce the count of blood eosinophil, which is an indication of improving lung function and is found in several asthma-related treatments.

ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Established in 2019, the company utilizes the repeatome—a previously overlooked segment of genetic material—to create novel treatment options. By identifying multiple drug targets and advancing several discovery programs, ROME Therapeutics aims to tap into this unexplored area of biology. The organization has assembled a team of experts in oncology, immunology, virology, and machine learning to lead its research and development efforts, which are designed to provide healthcare professionals with effective new treatments for patients suffering from these conditions.

Nimbus Therapeutics, based in Cambridge, Massachusetts, is a biotechnology company focused on discovering and developing innovative medicines for serious diseases, including metabolic disorders, cancer, and immune-inflammatory conditions. The company utilizes advanced computational technologies to create selective and potent small-molecule therapeutics. Among its notable projects is the Nimbus Apollo program, which features the lead candidate NDI-010976, an allosteric inhibitor targeting Acetyl-CoA Carboxylase (ACC). This compound is being developed for the treatment of non-alcoholic steatohepatitis (NASH) and has potential applications in hepatocellular carcinoma (HCC) and other diseases. NDI-010976 received Fast Track designation from the U.S. Food and Drug Administration in 2016, highlighting its significance in the clinical development pipeline. Nimbus Therapeutics has formed strategic partnerships to enhance its research and development capabilities, reinforcing its commitment to advancing treatment options for complex health challenges.

Chroma Medicine is a genomic medicine company based in Cambridge, Massachusetts, founded in 2021. The company focuses on epigenetic editing, aiming to revolutionize the treatment of genetically driven diseases. By utilizing epigenetics, which is nature's inherent mechanism for regulating genes, Chroma Medicine develops programmable epigenetic editors that target specific genes and control chromatin conformation. This innovative approach combines a DNA binding domain with epigenetic effector domains, providing medical practitioners with a new class of therapeutics that offers enhanced control over gene expression.

Superplastic is a character-based product and entertainment company. It creates limited edition art toys, apparel, games, and animation based on characters created in collaboration with some of the greatest artists in the world. Superplastic is founded on the principle that effort and scarcity are intrinsic components of value. The company appropriates the tools of mass media and mass production to create limited edition works of art for a limited audience. It was established in 2017 and is based in Burlington, Vermont.

Chronosphere, Inc. is a technology company that specializes in developing an open-source metrics data platform known as M3. Founded in 2019 and headquartered in New York, the company has additional offices in Seattle, Vilnius, and Warsaw. Chronosphere's platform provides comprehensive monitoring solutions for infrastructure, applications, and business metrics, enabling organizations to manage the complexities of cloud-native environments. By offering tools that help DevOps teams quickly identify and resolve issues across various layers of the technology stack, Chronosphere enhances operational reliability and supports data-driven decision-making. The platform is utilized by prominent brands to improve developer productivity, control costs, and enhance customer satisfaction.

Galileo, Inc. is a technology company that specializes in providing healthcare solutions through a mobile application, enabling direct access to clinical care and expertise via smartphones. Founded in 2014 and headquartered in New York, the company facilitates communication between healthcare providers and patients using advanced telecommunications technologies. Galileo delivers high-touch, data-driven, multi-specialty care to a diverse patient population, offering services over the phone and in various settings. The company is recognized by regional and national health plans, employers, and major corporations for its effectiveness in enhancing population health. Galileo's mission is to address complex healthcare challenges and foster closer connections between patients and providers.

Landis is an online real estate platform founded in 2018 and headquartered in New York, NY, that focuses on helping renters become homeowners. The company allows clients to choose their dream home, rent it, and purchase it within the first twelve months. In addition to facilitating this transition, Landis provides tools and incentives designed to assist clients in improving their credit scores and accumulating down payment savings. With a commitment to transparency and simplicity, Landis aims to create a seamless process for renters to transition to homeownership. The company also specializes in commercial real estate technology and residential offerings.

Fractyl Health, based in Lexington, Massachusetts, specializes in developing innovative medical device solutions for metabolic diseases, particularly type 2 diabetes and obesity. The company’s primary offering, Revita DMR, is a minimally invasive therapy that utilizes hydrothermal ablation to rejuvenate the duodenal lining, which can become compromised due to high-fat and high-sugar diets. By focusing on durable disease-modifying therapies rather than just symptomatic management, Fractyl Health aims to address the underlying causes of metabolic diseases, improving patient outcomes and reducing healthcare burdens. Founded in 2010 and originally named MedCatalyst, Inc., the company envisions a future where less invasive, device-based therapies provide effective solutions for large populations affected by metabolic disorders.

Merlin Labs is an innovative company focused on creating autonomous flight technology for advanced air travel, primarily utilizing fixed-wing aircraft. Founded in 2018 and headquartered in Boston, Massachusetts, the company develops a sophisticated aircraft autonomy system that employs artificial intelligence and machine learning, akin to the technology used in driverless cars. This system aims to facilitate the pilotless transportation of goods and eventually people, establishing a new infrastructure for aerial mobility.

Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease. The company was spun out of Pennsylvania-based Knopp, which published results from its phase 2 clinical trial last year that showed its oral drug candidate could reduce the count of blood eosinophil, which is an indication of improving lung function and is found in several asthma-related treatments.

FYTO, Inc. is a company based in Cambridge, Massachusetts, that focuses on developing plant-based feed production systems aimed at enhancing the sustainability of agriculture. Founded in 2019, FYTO specializes in creating nutrient-dense crops that require minimal resources, alongside cultivation and harvesting systems designed to ensure quality and consistency. The company's offerings include a variety of agricultural products such as animal feed, plant-based proteins, nutritional supplements, and bio-fertilizers. By adopting climate-friendly practices and methodologies, FYTO aims to support farmers globally in achieving improved economic and environmental outcomes in their agricultural operations.

Nava is a health insurance brokerage based in New York, dedicated to providing high-quality and affordable healthcare solutions for employers and their employees. The company offers a range of services, including healthcare tools, year-round employee advocacy, and ongoing plan measurement. These services are designed to help clients select and manage their healthcare plans effectively, ensuring that they can offer necessary benefits while also reducing overall costs. Through its innovative approach, Nava aims to enhance the healthcare experience for both employers and employees.

Strella Biotechnology, Inc. is a Philadelphia-based company that designs and manufactures sensor-based devices aimed at maximizing the freshness of produce throughout the supply chain. Founded in 2018 by Jacob Jordan and Katherine Sizov, the company specializes in ethylene detection technology, which assesses the ripeness of fruit by measuring the ethylene gas emitted during ripening. This innovation helps to optimize the produce supply chain by providing critical data that reduces spoilage and enhances the management of fresh produce. Strella Biotechnology leverages its patented technology to support efficiency and maintain quality in food distribution.

Invetx, Inc. is a biotechnology company focused on developing protein-based therapeutics for animal health care and veterinary medicine. Based in Boston, Massachusetts, Invetx's team comprises veterinary scientists and clinicians dedicated to discovering and creating biotherapeutics for both pets and farm animals. The company aims to enhance health outcomes in the animal health industry by leveraging biopharma technologies, supported by a network of experts in animal and human health. Through its innovative platform, Invetx is committed to advancing a portfolio of therapies and technologies designed to improve animal care and well-being.

LifeMine Therapeutics, Inc. is a biotechnology company focused on discovering new drug modalities from eukaryotic microbes, particularly fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, the company employs an integrated platform that combines genomics, artificial intelligence, and synthetic biology. This innovative Avatar-Rx platform utilizes high-throughput microbiology, data science, machine learning, genome engineering, and automation to explore the fungal biosphere for novel genetically encoded molecules with specific biological functions. By integrating chemoinformatic-assisted drug optimization and advanced chemical synthesis with biotransformation, LifeMine Therapeutics aims to advance a pipeline of new medicines into development.

Dbt Labs is a developer of an open-source analytics engineering tool aimed at empowering data analysts to create and share organizational knowledge. Founded in 2016 and headquartered in Philadelphia, Pennsylvania, the company provides a platform that enables users with SQL expertise to develop data transformation workflows efficiently. Its transformation workflow tool supports collaborative deployment of analytics code, adhering to software engineering practices such as modularity, portability, and thorough documentation. By facilitating data modeling, Dbt Labs helps teams streamline their analytics processes and enhance their data-driven decision-making capabilities.

RightHand Robotics, Inc. specializes in the manufacturing of robotic order-picking systems designed to enhance supply chain logistics and order fulfillment across various industries, including e-commerce, food handling, and flexible manufacturing. Founded in 2015, the company is headquartered in Cambridge, Massachusetts, with an additional office in Frankfurt, Germany. RightHand Robotics offers innovative solutions like the ReFlex SF, which features a 3D-printed palm equipped with advanced servos and compliant fingers, and the ReFlex TakkTile, a tactile sensor that aids in gentle object handling. Their technology enables robots to automatically grasp a wide range of items from bins and cases without the need for extensive data entry or parameter tuning, making their systems cost-effective and adaptable to changing business needs.

Genesis Global enables financial markets organizations to innovate at speed through a software application development platform, prepackaged solutions and deep expertise in capital markets and financial services. In supercharging developers to rapidly deliver high-performance, resilient and secure applications, Genesis replaces the buy vs. build challenge with a buy-to-build solution. The Genesis platform is designed with flexibility and performance at its core, providing developers with the frameworks, integrations and components required to automate manual workflows, enhance legacy systems and build entirely new applications. Featuring a resilient, real-time service-oriented architecture, Genesis excels across the performance envelope of low-latency, high-throughput and high-scalability, powering mission-critical applications at the world’s leading financial institutions. Strategically backed by Bank of America, BNY Mellon and Citi, Genesis Global has offices in Miami, New York, Charlotte, London, Leeds, São Paulo, Dublin and Bengaluru.

Scandit AG is a technology company based in Zurich, Switzerland, specializing in mobile computer vision and augmented reality solutions for enterprises. Founded in 2009, Scandit develops barcode scanning software that enhances scanning performance across various devices, including smartphones, tablets, and wearables. Its offerings include the Scandit Keyboard Wedge, Barcode Scanner SDK for the Web, and MatrixScan, which improve processes in retail, logistics, healthcare, and manufacturing. The company's solutions enable functionalities such as mobile shopping, self-checkout, inventory management, and asset tracking, while also facilitating contactless interactions. Scandit's products are utilized by notable clients such as 7-Eleven, Carrefour, and Johns Hopkins Hospital. By leveraging proprietary technology in computer vision and machine learning, Scandit aims to streamline operations, reduce costs, and enhance customer experiences across multiple industries. The company also maintains offices in San Francisco, Boston, London, and Warsaw.

Quartet Health, Inc. is a healthcare technology company that operates a cloud-based platform designed to enhance communication and collaboration between medical and behavioral health providers. Founded in 2014 and based in New York, the platform integrates with health plans and systems to deliver actionable insights and reports on behavioral health conditions, ultimately aiming to improve patient outcomes. By facilitating connections among physicians, mental health providers, and insurers, Quartet Health enhances access to mental health care that aligns with patients' preferences and clinical needs, while also supporting tools for patient self-management. This approach not only improves the quality of care but also contributes to lowering healthcare costs for patients.

Mabl Inc. is an intelligent test automation company based in Boston, Massachusetts, founded in 2016. It offers an automated testing service that leverages machine learning to identify regressions and automatically fix broken tests. The platform provides scriptless testing and integrates seamlessly into the continuous integration and continuous deployment (CI/CD) development lifecycle, allowing software teams to create and maintain reliable, auto-healing tests. By streamlining the testing process, Mabl enables organizations to enhance the speed and quality of their software releases, facilitating faster delivery of high-quality applications while helping developers and testers address bugs before they reach production.

RightHand Robotics, Inc. specializes in the manufacturing of robotic order-picking systems designed to enhance supply chain logistics and order fulfillment across various industries, including e-commerce, food handling, and flexible manufacturing. Founded in 2015, the company is headquartered in Cambridge, Massachusetts, with an additional office in Frankfurt, Germany. RightHand Robotics offers innovative solutions like the ReFlex SF, which features a 3D-printed palm equipped with advanced servos and compliant fingers, and the ReFlex TakkTile, a tactile sensor that aids in gentle object handling. Their technology enables robots to automatically grasp a wide range of items from bins and cases without the need for extensive data entry or parameter tuning, making their systems cost-effective and adaptable to changing business needs.

TMRW Life Sciences is a technology company focused on improving standards of safety, transparency, and accountability in the management of frozen eggs and embryos within the IVF sector. The company has developed the first automated cryo-management platform specifically designed for this purpose, which integrates a digital chain of custody with robotic storage and monitoring solutions. This innovative approach aims to replace traditional manual methods that have remained largely unchanged over the years, thereby significantly reducing the risk of errors that could have serious consequences. Founded in 2018 by Joshua Abram, Alan Murray, and Dr. Jeffrey Port, TMRW combines expertise in fertility, embryology, cryo-management, automation, software development, and robotics to enhance the specimen management process for clinics, facilitating advancements in IVF technology. The company is headquartered in New York, New York.

Ribon Therapeutics, Inc. is a biotechnology company based in Lexington, Massachusetts, focused on developing novel cancer therapies that target monoPARP proteins, which are essential regulators of cancer survival mechanisms. Established in 2015, Ribon is leveraging insights from its scientific founders and an experienced management team to create a proprietary drug discovery platform aimed at understanding the molecular actions and biological functions of monoPARPs. This platform enables the development of small molecule inhibitors designed to disrupt cancer cells' abilities to withstand stress, potentially leading to innovative treatments for cancer and other diseases. The company is supported by notable life science investors, positioning it for growth in the biopharmaceutical sector.

Merlin Labs is an innovative company focused on creating autonomous flight technology for advanced air travel, primarily utilizing fixed-wing aircraft. Founded in 2018 and headquartered in Boston, Massachusetts, the company develops a sophisticated aircraft autonomy system that employs artificial intelligence and machine learning, akin to the technology used in driverless cars. This system aims to facilitate the pilotless transportation of goods and eventually people, establishing a new infrastructure for aerial mobility.

Bowery Farming Inc. is a modern farming company based in New York that specializes in post-organic produce, offering products such as baby kale, lettuce, arugula, and basil. Founded in 2014, Bowery aims to revolutionize agriculture by using technology to create ideal indoor farming conditions. Its proprietary software, BoweryOS, integrates vision systems, automation, and machine learning to monitor and optimize plant growth continuously. This controlled environment allows Bowery to produce food using zero pesticides and 95% less water, achieving over 100 times the productivity of traditional farming on the same land footprint. Bowery's produce is available in select grocery stores, including Whole Foods and Foragers, and is featured on the menus of renowned restaurants in New York.

Overture Life, Inc. is a biotechnology company established in 2017 and headquartered in New York, New York. The company specializes in developing robotic technology and medical devices aimed at automating the in vitro fertilization (IVF) process. Overture Life's innovations include novel embryo testing methodologies and automated cryopreservation services, which help fertility clinics identify viable embryos prior to implantation. By streamlining the IVF process, Overture Life aims to make artificial insemination more accessible, reduce costs, optimize resource use, and improve success rates for practitioners and patients alike.

Dyno Therapeutics Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative adeno-associated virus (AAV) vectors for gene therapy applications. Founded in 2018, the company employs an artificial intelligence-powered platform that integrates next-generation DNA synthesis, high-throughput sequencing, and machine learning. This advanced approach allows Dyno Therapeutics to design and optimize cell-targeting capsids, which are crucial for the effective and safe delivery of gene therapies. By leveraging its technology, the company aims to provide medical researchers with novel AAV vectors that enhance the efficacy of in vivo therapeutic solutions.

Treeline Biosciences is a biotechnology company established in 2021 and based in Stamford, Connecticut. The company focuses on developing transformative precision medicines aimed at treating cancer and other serious health conditions. Utilizing a comprehensive drug discovery platform, Treeline combines mechanistic biology, medicinal chemistry, computational science, structural biology, and protein science to create innovative therapeutic solutions. Through its research and development efforts, Treeline aims to provide effective treatments to improve patient outcomes in oncology and beyond.

Tend is a modern dental care provider that aims to transform the patient experience by offering personalized and hassle-free services. Launched in October 2019, the company has established 25 locations across major cities including New York, Washington DC, Boston, Atlanta, Nashville, and Connecticut. Tend focuses on patient happiness in a calm and inviting environment, leveraging technology and a hospitality-driven approach alongside a highly skilled clinical team. By prioritizing comfort and efficiency, Tend has become one of the top-rated full-service dental practices in the country, employing over 650 team members to support its mission of delivering quality oral health care.

SecurityScorecard, Inc. is a cybersecurity firm that specializes in providing a comprehensive rating and continuous monitoring platform to assess the cybersecurity strength of businesses and their third-party vendors. Established in 2013 by experts in security and risk, the company offers a range of solutions, including ThreatMarket, a cloud-based vulnerability search engine that identifies and correlates security-risk indicators across multiple categories such as application security and network vulnerabilities. Its services support vendor risk management, board reporting, and cyber insurance underwriting for over 1,000 organizations, including Fortune 1000 companies globally. SecurityScorecard's innovative approach includes interactive tools like Score Planner for remediation planning, Scorecard Event Log for transparent score tracking, and Atlas for managing cybersecurity questionnaires and controls at scale. By providing real-time risk ratings that align with vendor cybersecurity assessments, SecurityScorecard enhances organizational resilience and improves communication of cybersecurity risks to stakeholders. The company is headquartered in New York, New York.

Genesis Global enables financial markets organizations to innovate at speed through a software application development platform, prepackaged solutions and deep expertise in capital markets and financial services. In supercharging developers to rapidly deliver high-performance, resilient and secure applications, Genesis replaces the buy vs. build challenge with a buy-to-build solution. The Genesis platform is designed with flexibility and performance at its core, providing developers with the frameworks, integrations and components required to automate manual workflows, enhance legacy systems and build entirely new applications. Featuring a resilient, real-time service-oriented architecture, Genesis excels across the performance envelope of low-latency, high-throughput and high-scalability, powering mission-critical applications at the world’s leading financial institutions. Strategically backed by Bank of America, BNY Mellon and Citi, Genesis Global has offices in Miami, New York, Charlotte, London, Leeds, São Paulo, Dublin and Bengaluru.

Snyk Ltd. is a software as a service company that provides a platform for identifying, fixing, and monitoring vulnerabilities in applications. Founded in 2015 and headquartered in London, with additional offices in Tel Aviv, Boston, and Ontario, Snyk offers a range of solutions tailored for developers and security teams. Its key products include Snyk Code, a developer-first static application security testing tool, and container vulnerability management for securing Docker images. The platform also supports application security management, licensing compliance, and infrastructure as code security, ensuring that all components of modern applications are secure. Snyk’s Developer Security Platform integrates seamlessly into developers' workflows, promoting collaboration between development and security teams. The company serves over 1,200 customers globally, including notable organizations like Google and Salesforce, and has formed a strategic partnership with Rapid7. Snyk is recognized for its contributions to enhancing application security in an increasingly digital landscape.

TScan Therapeutics is a biopharmaceutical company dedicated to discovering and developing innovative T cell receptor (TCR) engineered therapies to combat various cancers. Based in Waltham, Massachusetts, the company focuses on TCR-T therapies for both liquid cancers and solid tumors. Its lead candidates, TSC-100 and TSC-101, are designed to address hematologic malignancies, specifically targeting residual leukemia and preventing relapse after hematopoietic stem cell transplantation. In addition, TScan is advancing a multiplexed TCR-T therapy program aimed at treating a range of solid tumors. The company's proprietary platform identifies clinically relevant T cell antigens and minimizes off-target effects, enhancing the precision of its therapies. Founded in 2018, TScan Therapeutics is committed to improving outcomes for patients with serious diseases.

Verve Therapeutics, Inc. is a genetic medicines company focused on innovative treatments for cardiovascular disease through gene editing. Founded in 2018 and based in Cambridge, Massachusetts, with a research facility in Philadelphia, the company aims to shift the management of cardiovascular conditions from chronic treatments to single-course gene editing therapies. Its initial programs concentrate on the PCSK9 and ANGPTL3 genes, which are known to significantly impact blood lipid levels, a major factor in cardiovascular disease. Verve Therapeutics collaborates with partners such as Beam Therapeutics and Verily to enhance its gene editing delivery technologies. The company is staffed by a team of experts in cardiovascular medicine, human genetics, and drug development, positioning itself to address the challenges of cardiovascular health effectively.

Cockroach Labs, Inc. is a developer of open-source database software, primarily known for its distributed SQL database, CockroachDB. Founded in 2015 and headquartered in New York, with an additional office in Cambridge, Massachusetts, the company provides a cloud-native platform designed for modern application development. CockroachDB allows organizations to build scalable applications that can withstand various types of failures, including those at the disk, machine, rack, and datacenter levels, with minimal disruption and no manual intervention. The database supports strongly consistent ACID transactions and offers an SQL API for data manipulation and querying. Its software is utilized by a diverse range of customers, from startups to Fortune 500 companies, across various industries, providing enterprise-grade disaster recovery services and enabling rapid development without compromising on consistency.

EQRx, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on transforming the drug discovery and delivery process to address the rising costs of medicines. Founded in 2019, EQRx aims to provide a market-based solution by leveraging advances in science and technology while collaborating with various healthcare stakeholders. The company has over ten programs in its pipeline targeting oncology and immune-inflammatory conditions, which include clinical and preclinical stages, as well as drug engineering initiatives. Among its key programs are Aumolertinib, Lerociclib, Sugemalimab, and Nofazinlimab. Through its innovative approach, EQRx seeks to develop high-quality, patent-protected medicines more efficiently and cost-effectively than traditional pharmaceutical methods.

LifeMine Therapeutics, Inc. is a biotechnology company focused on discovering new drug modalities from eukaryotic microbes, particularly fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, the company employs an integrated platform that combines genomics, artificial intelligence, and synthetic biology. This innovative Avatar-Rx platform utilizes high-throughput microbiology, data science, machine learning, genome engineering, and automation to explore the fungal biosphere for novel genetically encoded molecules with specific biological functions. By integrating chemoinformatic-assisted drug optimization and advanced chemical synthesis with biotransformation, LifeMine Therapeutics aims to advance a pipeline of new medicines into development.

SingleStore, Inc. is a provider of a relational database designed for cloud and on-premises transactions and analytics. The company offers a cloud database-as-a-service, known as SingleStore Managed Service, which enables analytics on the cloud of choice. Its flagship product, SingleStore DB, is a distributed SQL database that supports operational analytics on bare metal and hybrid cloud environments. SingleStore specializes in modernizing data platforms, securing government workloads, and facilitating IoT analytics, customer interactions, and risk management. It caters to a diverse range of industries, including financial services, media communications, energy, government, and retail. Founded in 2011 and headquartered in San Francisco, California, the company has additional offices in Seattle, Boston, Portland, Lisbon, and London. Initially known as MemSQL Inc., it rebranded to SingleStore, Inc. in October 2020.

HODINKEE, Inc. is a prominent online platform that combines media and retail to cater to watch enthusiasts. Founded in 2008 and based in New York, the company operates an online magazine that features in-depth reviews, critiques, and articles on wristwatches, as well as industry news and trends. In addition to its media presence, HODINKEE offers a curated selection of vintage watches and menswear accessories through its e-boutique and pop-up shops across the United States. The platform also produces a designated podcast and publishes a bi-annual print magazine, reinforcing its commitment to engaging storytelling and authentic content. Overall, HODINKEE aims to provide consumers with access to luxury watches and accessories in a manner that is approachable and trustworthy.

Superplastic is a character-based product and entertainment company. It creates limited edition art toys, apparel, games, and animation based on characters created in collaboration with some of the greatest artists in the world. Superplastic is founded on the principle that effort and scarcity are intrinsic components of value. The company appropriates the tools of mass media and mass production to create limited edition works of art for a limited audience. It was established in 2017 and is based in Burlington, Vermont.

Tend is a modern dental care provider that aims to transform the patient experience by offering personalized and hassle-free services. Launched in October 2019, the company has established 25 locations across major cities including New York, Washington DC, Boston, Atlanta, Nashville, and Connecticut. Tend focuses on patient happiness in a calm and inviting environment, leveraging technology and a hospitality-driven approach alongside a highly skilled clinical team. By prioritizing comfort and efficiency, Tend has become one of the top-rated full-service dental practices in the country, employing over 650 team members to support its mission of delivering quality oral health care.

Our first app, HAGS: Yearbook Signatures, let let tens of thousands of students sign their yearbooks through Snapchat. HAGS will be relaunching as an entirely new space for high school students to interact with their class. Based in New York.

UJET, Inc. specializes in developing customer support software and platform solutions that enhance customer communications. Founded in 2015 and headquartered in San Francisco, with additional offices in New York and Seoul, the company offers a cloud contact center platform that integrates seamlessly with major customer relationship management systems like Salesforce, Zendesk, and Kustomer. UJET's platform is designed for the smartphone era, modernizing digital and in-app customer experiences while eliminating the need for customers to switch between different communication channels. By utilizing multiple voices, online messaging, and mobile features, UJET assists customer service agents in managing incoming calls and resolving issues efficiently. The incorporation of artificial intelligence across its services further automates processes and improves interaction quality. Additionally, UJET provides a wait time messaging tool that offers live updates to customers while they are on hold, enhancing overall service satisfaction.

Sana Biotechnology is a biotechnology company based in Seattle, Washington, with additional offices in South San Francisco, California, and Cambridge, Massachusetts. Founded in 2018, the company specializes in developing engineered cells as medicines to treat a variety of diseases. Sana Biotechnology focuses on reprogramming cells in the body and replacing damaged cells and tissues, leveraging recent scientific advancements to create new therapeutic options. The company's research spans multiple therapeutic areas with significant unmet needs, including oncology, diabetes, B-cell-mediated autoimmune disorders, and central nervous system conditions. Its pipeline includes various product candidates aimed at addressing these challenges through innovative cell engineering programs.

Verve Therapeutics, Inc. is a genetic medicines company focused on innovative treatments for cardiovascular disease through gene editing. Founded in 2018 and based in Cambridge, Massachusetts, with a research facility in Philadelphia, the company aims to shift the management of cardiovascular conditions from chronic treatments to single-course gene editing therapies. Its initial programs concentrate on the PCSK9 and ANGPTL3 genes, which are known to significantly impact blood lipid levels, a major factor in cardiovascular disease. Verve Therapeutics collaborates with partners such as Beam Therapeutics and Verily to enhance its gene editing delivery technologies. The company is staffed by a team of experts in cardiovascular medicine, human genetics, and drug development, positioning itself to address the challenges of cardiovascular health effectively.

PatientPing, Inc. is a health technology company that has established a national care coordination network designed to connect healthcare providers with real-time notifications whenever patients receive care. The network encompasses a diverse group of healthcare personnel, including physicians, nurses, case managers, and care coordinators across various settings such as hospitals, emergency departments, and skilled nursing facilities. PatientPing offers technology solutions tailored to Accountable Care Organizations (ACOs) and other healthcare providers, facilitating improved collaboration and information sharing. One of its key tools, Spotlights, leverages real-time data to identify utilization and performance trends in patient care. Founded in 2013 and headquartered in Boston, Massachusetts, PatientPing operates as a subsidiary of SVB Leerink Holdings LLC and maintains a strategic partnership with MedAllies, Inc. By fostering connections among care teams, PatientPing aims to enhance the quality and efficiency of healthcare delivery, ultimately leading to better patient outcomes.

Scandit AG is a technology company based in Zurich, Switzerland, specializing in mobile computer vision and augmented reality solutions for enterprises. Founded in 2009, Scandit develops barcode scanning software that enhances scanning performance across various devices, including smartphones, tablets, and wearables. Its offerings include the Scandit Keyboard Wedge, Barcode Scanner SDK for the Web, and MatrixScan, which improve processes in retail, logistics, healthcare, and manufacturing. The company's solutions enable functionalities such as mobile shopping, self-checkout, inventory management, and asset tracking, while also facilitating contactless interactions. Scandit's products are utilized by notable clients such as 7-Eleven, Carrefour, and Johns Hopkins Hospital. By leveraging proprietary technology in computer vision and machine learning, Scandit aims to streamline operations, reduce costs, and enhance customer experiences across multiple industries. The company also maintains offices in San Francisco, Boston, London, and Warsaw.

Owkin is an artificial intelligence company founded in 2016 with offices in New York and Paris, focused on improving patient outcomes through innovative technology. The company utilizes AI to enhance drug discovery and development, particularly in oncology, by identifying new drug candidates, de-risking clinical trials, and creating diagnostic tools. Owkin's offerings include Okwin Lab, which connects data by therapeutic area; Okwin Loop, which features validated models; and a comprehensive software stack for full-service solutions. The company employs federated learning, enabling collaboration among medical and biopharma partners to extract insights from disparate datasets while safeguarding patient privacy. Owkin has developed a catalog of 30 validated models, with an additional 40 in development, and has raised over $255 million in funding, achieving unicorn status in November 2021. Co-founded by Thomas Clozel and Gilles Wainrib, Owkin aims to transform the landscape of healthcare by delivering tailored treatments for individual patients.

Cockroach Labs, Inc. is a developer of open-source database software, primarily known for its distributed SQL database, CockroachDB. Founded in 2015 and headquartered in New York, with an additional office in Cambridge, Massachusetts, the company provides a cloud-native platform designed for modern application development. CockroachDB allows organizations to build scalable applications that can withstand various types of failures, including those at the disk, machine, rack, and datacenter levels, with minimal disruption and no manual intervention. The database supports strongly consistent ACID transactions and offers an SQL API for data manipulation and querying. Its software is utilized by a diverse range of customers, from startups to Fortune 500 companies, across various industries, providing enterprise-grade disaster recovery services and enabling rapid development without compromising on consistency.

ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Established in 2019, the company utilizes the repeatome—a previously overlooked segment of genetic material—to create novel treatment options. By identifying multiple drug targets and advancing several discovery programs, ROME Therapeutics aims to tap into this unexplored area of biology. The organization has assembled a team of experts in oncology, immunology, virology, and machine learning to lead its research and development efforts, which are designed to provide healthcare professionals with effective new treatments for patients suffering from these conditions.

Cerevance LLC is a biotechnology company focused on developing innovative therapeutics for neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and other chronic neurodegenerative conditions. Founded in 2016 and headquartered in Boston, Massachusetts, with an additional office in Cambridge, United Kingdom, the company utilizes its NETSseq platform to profile specific brain cell types, including neurons and glial cells, using a repository of over 15,000 human brain tissue samples. This platform provides detailed expression and epigenetic data, allowing Cerevance to identify promising therapeutic targets for central nervous system diseases. Through its research, the company aims to advance new medicines that can potentially address the underlying mechanisms of these debilitating conditions.

EQRx, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on transforming the drug discovery and delivery process to address the rising costs of medicines. Founded in 2019, EQRx aims to provide a market-based solution by leveraging advances in science and technology while collaborating with various healthcare stakeholders. The company has over ten programs in its pipeline targeting oncology and immune-inflammatory conditions, which include clinical and preclinical stages, as well as drug engineering initiatives. Among its key programs are Aumolertinib, Lerociclib, Sugemalimab, and Nofazinlimab. Through its innovative approach, EQRx seeks to develop high-quality, patent-protected medicines more efficiently and cost-effectively than traditional pharmaceutical methods.

TScan Therapeutics is a biopharmaceutical company dedicated to discovering and developing innovative T cell receptor (TCR) engineered therapies to combat various cancers. Based in Waltham, Massachusetts, the company focuses on TCR-T therapies for both liquid cancers and solid tumors. Its lead candidates, TSC-100 and TSC-101, are designed to address hematologic malignancies, specifically targeting residual leukemia and preventing relapse after hematopoietic stem cell transplantation. In addition, TScan is advancing a multiplexed TCR-T therapy program aimed at treating a range of solid tumors. The company's proprietary platform identifies clinically relevant T cell antigens and minimizes off-target effects, enhancing the precision of its therapies. Founded in 2018, TScan Therapeutics is committed to improving outcomes for patients with serious diseases.

Kitchen United, Inc. is a food production facility provider that caters to restaurants by offering shared commercial kitchen spaces and business intelligence solutions. Founded in 2017 and headquartered in Pasadena, California, the company enables entrepreneurial caterers, pop-ups, mobile food vendors, and start-ups to expand their operations with minimal risk and investment. Kitchen United's facilities support food delivery and pick-up services, allowing restaurant brands to grow profitably. With locations in major cities including Austin, Chicago, Los Angeles, San Francisco, New York City, and Scottsdale, Kitchen United provides a comprehensive solution that helps food service providers maximize their business potential through access to high-quality kitchen resources and strategic insights.

Snyk Ltd. is a software as a service company that provides a platform for identifying, fixing, and monitoring vulnerabilities in applications. Founded in 2015 and headquartered in London, with additional offices in Tel Aviv, Boston, and Ontario, Snyk offers a range of solutions tailored for developers and security teams. Its key products include Snyk Code, a developer-first static application security testing tool, and container vulnerability management for securing Docker images. The platform also supports application security management, licensing compliance, and infrastructure as code security, ensuring that all components of modern applications are secure. Snyk’s Developer Security Platform integrates seamlessly into developers' workflows, promoting collaboration between development and security teams. The company serves over 1,200 customers globally, including notable organizations like Google and Salesforce, and has formed a strategic partnership with Rapid7. Snyk is recognized for its contributions to enhancing application security in an increasingly digital landscape.

Cockroach Labs, Inc. is a developer of open-source database software, primarily known for its distributed SQL database, CockroachDB. Founded in 2015 and headquartered in New York, with an additional office in Cambridge, Massachusetts, the company provides a cloud-native platform designed for modern application development. CockroachDB allows organizations to build scalable applications that can withstand various types of failures, including those at the disk, machine, rack, and datacenter levels, with minimal disruption and no manual intervention. The database supports strongly consistent ACID transactions and offers an SQL API for data manipulation and querying. Its software is utilized by a diverse range of customers, from startups to Fortune 500 companies, across various industries, providing enterprise-grade disaster recovery services and enabling rapid development without compromising on consistency.

TScan Therapeutics is a biopharmaceutical company dedicated to discovering and developing innovative T cell receptor (TCR) engineered therapies to combat various cancers. Based in Waltham, Massachusetts, the company focuses on TCR-T therapies for both liquid cancers and solid tumors. Its lead candidates, TSC-100 and TSC-101, are designed to address hematologic malignancies, specifically targeting residual leukemia and preventing relapse after hematopoietic stem cell transplantation. In addition, TScan is advancing a multiplexed TCR-T therapy program aimed at treating a range of solid tumors. The company's proprietary platform identifies clinically relevant T cell antigens and minimizes off-target effects, enhancing the precision of its therapies. Founded in 2018, TScan Therapeutics is committed to improving outcomes for patients with serious diseases.

Yellowbrick Learning, Inc. operates an online platform designed to facilitate career exploration and development for individuals interested in creative industries such as fashion, sports, beauty, music, and media. Founded in 2013 and based in New York, the company partners with leading universities, brands, and employers to create educational experiences that help students build relevant skills and gain industry insights. By focusing on the alignment of personal passions with career opportunities, Yellowbrick aims to empower the next generation of talent to identify, pursue, and advance their careers within the creative arts and entertainment sectors.

Lemonade, Inc. is an insurance provider based in New York, offering a range of products in the United States and Europe. Founded in 2015, the company specializes in homeowners and renters insurance, covering stolen or damaged property and personal liability for accidents involving customers. Additionally, Lemonade offers landlord insurance policies for property owners renting out their units. The company distinguishes itself by utilizing artificial intelligence and behavioral economics to streamline the insurance process, replacing traditional brokers and paperwork with automated systems. As a licensed insurance carrier, Lemonade aims to enhance customer experience while promoting social good.

Lola.com is an easy-to-use travel management tool that helps companies book, report, and save on business travel. Life becomes simpler with employee friendly business travel policies, fun travel tracking tools, and transparent spend reporting for business travel managers. For the business travelers, it enables easy flight and hotel booking, team destination sharing, loyalty points from the actual hotels and airlines, and 24/7 agent support. Its book on behalf feature lets executive assistants, easily book travel like a boss. Founded on 2015, Lola.com works for both employers and employees. It is headquartered in Boston, Massachusetts.

Owkin is an artificial intelligence company founded in 2016 with offices in New York and Paris, focused on improving patient outcomes through innovative technology. The company utilizes AI to enhance drug discovery and development, particularly in oncology, by identifying new drug candidates, de-risking clinical trials, and creating diagnostic tools. Owkin's offerings include Okwin Lab, which connects data by therapeutic area; Okwin Loop, which features validated models; and a comprehensive software stack for full-service solutions. The company employs federated learning, enabling collaboration among medical and biopharma partners to extract insights from disparate datasets while safeguarding patient privacy. Owkin has developed a catalog of 30 validated models, with an additional 40 in development, and has raised over $255 million in funding, achieving unicorn status in November 2021. Co-founded by Thomas Clozel and Gilles Wainrib, Owkin aims to transform the landscape of healthcare by delivering tailored treatments for individual patients.

Beam Therapeutics Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing precision genetic medicines using its innovative base editing technology. Founded in 2017, the company aims to provide lifelong cures for patients with serious diseases. Its therapeutic portfolio includes treatments for sickle cell disease, beta-thalassemia, pediatric T-cell acute lymphoblastic leukemia, pediatric acute myeloid leukemia, alpha-1 antitrypsin deficiency, and glycogen storage disorder 1A, as well as therapies for ocular and central nervous system disorders. Beam's base editing technology allows for targeted modifications at a single base in the genome without creating double-stranded breaks in DNA, positioning it as a pioneer in the field of genetic medicine. The company's pipeline includes several programs, such as BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201, reflecting its commitment to advancing genetic therapies.

CTRL-Labs Corporation, founded in 2015 and based in New York City, specializes in developing non-invasive neural interface technology aimed at enhancing the interaction between humans and machines. The company's flagship product, the CTRL-kit, is a wireless wristband equipped with sensors that captures neural signals, allowing users to control digital devices through simple electronic pulses. This innovative platform is designed to support various applications in virtual reality, augmented reality, robotics, productivity, and clinical research. By providing developers with a software development kit (SDK) and application programming interface (API), CTRL-Labs enables the integration of neural control into their applications. The company's long-term vision focuses on fostering mass consumer adoption of neural interfaces, establishing a new standard for human-machine collaboration that transforms how users engage with technology.

2nd Address, Inc. operates an online marketplace that facilitates the booking and listing of furnished apartments, homes, and condominiums for both short-term and long-term rentals. Founded in 2014 and based in San Francisco, the company provides a platform that simplifies the leasing process for tenants and landlords in major urban markets across the United States, including cities like Washington, D.C., San Francisco, New York, and Chicago. The platform caters to a range of customers, from large corporations such as Google and Microsoft to smaller businesses, by offering a diverse selection of properties and flexible leasing options. Formerly known as HomeSuite, Inc., the company rebranded in November 2017 to enhance its identity in the marketplace.

Managed by Q Inc. operates a workplace management platform that facilitates the efficient operation of offices. The company provides a comprehensive suite of services, including cleaning, maintenance, IT support, and security, alongside workplace staffing and project management services. Its technology platform connects businesses to essential services for managing their workspaces, enabling tasks such as cleaning schedules, supply replenishment, and maintenance through an intuitive application. Founded in 2013 and based in New York, the company also emphasizes economic empowerment by creating jobs for its operators and supporting small businesses. As a subsidiary of Eden Technologies, Inc., Managed by Q is active in major cities including New York, Los Angeles, Chicago, and San Francisco, aiming to redefine office management and enhance workplace productivity.

Relay Therapeutics is a clinical-stage precision medicine company based in Cambridge, Massachusetts, focused on transforming the drug discovery process, particularly in targeted oncology. Utilizing its innovative Dynamo platform, the company combines advanced computational techniques with experimental methods to enhance small molecule therapeutic discovery. Relay Therapeutics is developing several product candidates, including RLY-1971, an oral inhibitor targeting the SHP2 protein, currently in Phase 1 trials for advanced solid tumors; RLY-4008, a selective inhibitor for patients with FGFR2 alterations; and RLY-PI3K1047, aimed at cancer-associated mutations of the PI3K alpha protein. Founded in 2015, Relay Therapeutics is dedicated to addressing complex diseases through its unique approach to drug discovery.

RightHand Robotics, Inc. specializes in the manufacturing of robotic order-picking systems designed to enhance supply chain logistics and order fulfillment across various industries, including e-commerce, food handling, and flexible manufacturing. Founded in 2015, the company is headquartered in Cambridge, Massachusetts, with an additional office in Frankfurt, Germany. RightHand Robotics offers innovative solutions like the ReFlex SF, which features a 3D-printed palm equipped with advanced servos and compliant fingers, and the ReFlex TakkTile, a tactile sensor that aids in gentle object handling. Their technology enables robots to automatically grasp a wide range of items from bins and cases without the need for extensive data entry or parameter tuning, making their systems cost-effective and adaptable to changing business needs.

Bowery Farming Inc. is a modern farming company based in New York that specializes in post-organic produce, offering products such as baby kale, lettuce, arugula, and basil. Founded in 2014, Bowery aims to revolutionize agriculture by using technology to create ideal indoor farming conditions. Its proprietary software, BoweryOS, integrates vision systems, automation, and machine learning to monitor and optimize plant growth continuously. This controlled environment allows Bowery to produce food using zero pesticides and 95% less water, achieving over 100 times the productivity of traditional farming on the same land footprint. Bowery's produce is available in select grocery stores, including Whole Foods and Foragers, and is featured on the menus of renowned restaurants in New York.

Kitchen United, Inc. is a food production facility provider that caters to restaurants by offering shared commercial kitchen spaces and business intelligence solutions. Founded in 2017 and headquartered in Pasadena, California, the company enables entrepreneurial caterers, pop-ups, mobile food vendors, and start-ups to expand their operations with minimal risk and investment. Kitchen United's facilities support food delivery and pick-up services, allowing restaurant brands to grow profitably. With locations in major cities including Austin, Chicago, Los Angeles, San Francisco, New York City, and Scottsdale, Kitchen United provides a comprehensive solution that helps food service providers maximize their business potential through access to high-quality kitchen resources and strategic insights.

Snyk Ltd. is a software as a service company that provides a platform for identifying, fixing, and monitoring vulnerabilities in applications. Founded in 2015 and headquartered in London, with additional offices in Tel Aviv, Boston, and Ontario, Snyk offers a range of solutions tailored for developers and security teams. Its key products include Snyk Code, a developer-first static application security testing tool, and container vulnerability management for securing Docker images. The platform also supports application security management, licensing compliance, and infrastructure as code security, ensuring that all components of modern applications are secure. Snyk’s Developer Security Platform integrates seamlessly into developers' workflows, promoting collaboration between development and security teams. The company serves over 1,200 customers globally, including notable organizations like Google and Salesforce, and has formed a strategic partnership with Rapid7. Snyk is recognized for its contributions to enhancing application security in an increasingly digital landscape.

Mabl Inc. is an intelligent test automation company based in Boston, Massachusetts, founded in 2016. It offers an automated testing service that leverages machine learning to identify regressions and automatically fix broken tests. The platform provides scriptless testing and integrates seamlessly into the continuous integration and continuous deployment (CI/CD) development lifecycle, allowing software teams to create and maintain reliable, auto-healing tests. By streamlining the testing process, Mabl enables organizations to enhance the speed and quality of their software releases, facilitating faster delivery of high-quality applications while helping developers and testers address bugs before they reach production.

Yesware, Inc. is a company that creates a prescriptive sales platform aimed at enhancing the productivity of sales professionals and startups globally. Founded in 2010 and headquartered in Boston, Massachusetts, with an additional office in San Francisco, Yesware offers an all-in-one toolkit for sales within popular email clients like Outlook and Gmail. The platform allows users to track emails, schedule messages, set reminders, and make calls directly from their inboxes. It also features customizable email templates and analytics to help sales teams monitor performance and identify effective strategies. With over 1.2 million installations, Yesware serves a diverse clientele, from small businesses to large enterprises, including notable organizations like Yelp and Twitter. The company is focused on improving customer interactions and streamlining sales processes to deliver better buying experiences.

Scandit AG is a technology company based in Zurich, Switzerland, specializing in mobile computer vision and augmented reality solutions for enterprises. Founded in 2009, Scandit develops barcode scanning software that enhances scanning performance across various devices, including smartphones, tablets, and wearables. Its offerings include the Scandit Keyboard Wedge, Barcode Scanner SDK for the Web, and MatrixScan, which improve processes in retail, logistics, healthcare, and manufacturing. The company's solutions enable functionalities such as mobile shopping, self-checkout, inventory management, and asset tracking, while also facilitating contactless interactions. Scandit's products are utilized by notable clients such as 7-Eleven, Carrefour, and Johns Hopkins Hospital. By leveraging proprietary technology in computer vision and machine learning, Scandit aims to streamline operations, reduce costs, and enhance customer experiences across multiple industries. The company also maintains offices in San Francisco, Boston, London, and Warsaw.

Peerspace operates a marketplace for companies and individuals looking for short-term workspaces. Its platform enables users to search, message, and book various spaces that include corporate and private event spaces, photo studios, artist spaces, conference rooms, industrial-chic event spaces, daylight photo studios, video sound stage and photography studios, production studios, converted warehouses, train stations, photo and video spaces, sports car museum event spaces, and courtyards. Peerspace serves customers in San Francisco Bay Area, Los Angeles, New York, Seattle, Austin, and Chicago. Matt Bendett and Rony Chammas founded the company, with its headquarters in San Francisco in California.

Tamr, Inc. is an enterprise data unification company that specializes in providing data management solutions. The company offers a platform that utilizes machine learning combined with human expertise to identify and integrate diverse internal and external data sources, thereby enabling organizations to manage siloed data effectively. Tamr's services include enterprise data preparation, clinical data conversion, procurement optimization, and customer data integration, catering to various sectors such as financial services, life sciences, government, and manufacturing. Founded in 2013 by experienced professionals in the database industry, Tamr is headquartered in Cambridge, Massachusetts, with additional offices in major cities including New York, Seattle, San Francisco, Washington, D.C., and London. The company aims to deliver valuable insights from data, supporting clients in achieving successful business outcomes.

Openbay, Inc. is a company that specializes in providing software-as-a-service (SaaS) solutions for the automotive care industry. Founded in 2011 and based in Cambridge, Massachusetts, Openbay operates an online marketplace that connects vehicle owners with automotive repair professionals. This platform allows users to find, compare, book, and pay for a wide range of vehicle maintenance and repair services, including air conditioning repairs, battery replacements, brake services, oil changes, and tire replacements, among others. The company collaborates with various service providers, including car dealerships, national chains, independent shops, and mobile mechanics. Openbay has received recognition for its innovative approach to making automotive services more accessible and cost-effective for consumers, attracting venture capital backing and media attention from prominent outlets.

CTRL-Labs Corporation, founded in 2015 and based in New York City, specializes in developing non-invasive neural interface technology aimed at enhancing the interaction between humans and machines. The company's flagship product, the CTRL-kit, is a wireless wristband equipped with sensors that captures neural signals, allowing users to control digital devices through simple electronic pulses. This innovative platform is designed to support various applications in virtual reality, augmented reality, robotics, productivity, and clinical research. By providing developers with a software development kit (SDK) and application programming interface (API), CTRL-Labs enables the integration of neural control into their applications. The company's long-term vision focuses on fostering mass consumer adoption of neural interfaces, establishing a new standard for human-machine collaboration that transforms how users engage with technology.

Owkin is an artificial intelligence company founded in 2016 with offices in New York and Paris, focused on improving patient outcomes through innovative technology. The company utilizes AI to enhance drug discovery and development, particularly in oncology, by identifying new drug candidates, de-risking clinical trials, and creating diagnostic tools. Owkin's offerings include Okwin Lab, which connects data by therapeutic area; Okwin Loop, which features validated models; and a comprehensive software stack for full-service solutions. The company employs federated learning, enabling collaboration among medical and biopharma partners to extract insights from disparate datasets while safeguarding patient privacy. Owkin has developed a catalog of 30 validated models, with an additional 40 in development, and has raised over $255 million in funding, achieving unicorn status in November 2021. Co-founded by Thomas Clozel and Gilles Wainrib, Owkin aims to transform the landscape of healthcare by delivering tailored treatments for individual patients.

Celsius Therapeutics is a biotechnology company focused on developing precision medicines for patients with cancer and autoimmune diseases. Founded in 2018 and based in Cambridge, Massachusetts, the company employs a team of scientists, technologists, computational biologists, clinicians, and drug hunters. Utilizing single-cell genomic analysis and machine learning techniques, Celsius Therapeutics aims to discover and create innovative therapies that can lead to significant improvements in patient outcomes. The company's research efforts are centered on identifying new drug candidates that address unmet medical needs in the therapeutic landscape.

SingleStore, Inc. is a provider of a relational database designed for cloud and on-premises transactions and analytics. The company offers a cloud database-as-a-service, known as SingleStore Managed Service, which enables analytics on the cloud of choice. Its flagship product, SingleStore DB, is a distributed SQL database that supports operational analytics on bare metal and hybrid cloud environments. SingleStore specializes in modernizing data platforms, securing government workloads, and facilitating IoT analytics, customer interactions, and risk management. It caters to a diverse range of industries, including financial services, media communications, energy, government, and retail. Founded in 2011 and headquartered in San Francisco, California, the company has additional offices in Seattle, Boston, Portland, Lisbon, and London. Initially known as MemSQL Inc., it rebranded to SingleStore, Inc. in October 2020.

Rocketrip, Inc. is a travel management platform that incentivizes employees to make cost-effective travel decisions for business purposes. Founded in 2013 and based in New York, the platform provides real-time insights into travel expenses, helping employees understand reasonable spending limits. By establishing a custom-calibrated Price to Beat, Rocketrip motivates employees to select lower-cost options for flights, car rentals, and hotel accommodations, thereby enabling them to earn rewards for saving the company money. The platform integrates seamlessly with existing online booking processes, ensuring minimal disruption. Rocketrip is utilized by notable enterprises such as iHeartMedia, Feld Entertainment, and Twitter, and operates as a subsidiary of Mondee Holdings Inc.

TheSkimm, Inc. is a digital media company founded in 2012 and based in New York, specializing in delivering concise and relevant information to educated professionals, particularly women. Its flagship product is a daily newsletter that breaks down news, trends, and policies impacting women's lives, allowing them to make informed decisions. TheSkimm aims to empower its audience by providing reliable, non-partisan content that integrates easily into daily routines. In addition to the Daily Skimm, the company's offerings include various newsletters such as Skimm Money, a podcast, and a mobile app. TheSkimm also operates Skimm Studios, which produces video and audio content, and SKM Lab, an in-house creative agency for brand engagement. Committed to social impact, theSkimm supports initiatives like Skimm Your Ballot to encourage voter participation and the #ShowUsYourLeave movement to promote transparency in paid family leave. Co-founded by Carly Zakin and Danielle Weisberg, theSkimm has developed a loyal audience and continues to innovate within the media landscape.

Quartet Health, Inc. is a healthcare technology company that operates a cloud-based platform designed to enhance communication and collaboration between medical and behavioral health providers. Founded in 2014 and based in New York, the platform integrates with health plans and systems to deliver actionable insights and reports on behavioral health conditions, ultimately aiming to improve patient outcomes. By facilitating connections among physicians, mental health providers, and insurers, Quartet Health enhances access to mental health care that aligns with patients' preferences and clinical needs, while also supporting tools for patient self-management. This approach not only improves the quality of care but also contributes to lowering healthcare costs for patients.

Lemonade, Inc. is an insurance provider based in New York, offering a range of products in the United States and Europe. Founded in 2015, the company specializes in homeowners and renters insurance, covering stolen or damaged property and personal liability for accidents involving customers. Additionally, Lemonade offers landlord insurance policies for property owners renting out their units. The company distinguishes itself by utilizing artificial intelligence and behavioral economics to streamline the insurance process, replacing traditional brokers and paperwork with automated systems. As a licensed insurance carrier, Lemonade aims to enhance customer experience while promoting social good.

Relay Therapeutics is a clinical-stage precision medicine company based in Cambridge, Massachusetts, focused on transforming the drug discovery process, particularly in targeted oncology. Utilizing its innovative Dynamo platform, the company combines advanced computational techniques with experimental methods to enhance small molecule therapeutic discovery. Relay Therapeutics is developing several product candidates, including RLY-1971, an oral inhibitor targeting the SHP2 protein, currently in Phase 1 trials for advanced solid tumors; RLY-4008, a selective inhibitor for patients with FGFR2 alterations; and RLY-PI3K1047, aimed at cancer-associated mutations of the PI3K alpha protein. Founded in 2015, Relay Therapeutics is dedicated to addressing complex diseases through its unique approach to drug discovery.

Fractyl Health, based in Lexington, Massachusetts, specializes in developing innovative medical device solutions for metabolic diseases, particularly type 2 diabetes and obesity. The company’s primary offering, Revita DMR, is a minimally invasive therapy that utilizes hydrothermal ablation to rejuvenate the duodenal lining, which can become compromised due to high-fat and high-sugar diets. By focusing on durable disease-modifying therapies rather than just symptomatic management, Fractyl Health aims to address the underlying causes of metabolic diseases, improving patient outcomes and reducing healthcare burdens. Founded in 2010 and originally named MedCatalyst, Inc., the company envisions a future where less invasive, device-based therapies provide effective solutions for large populations affected by metabolic disorders.

LifeMine Therapeutics, Inc. is a biotechnology company focused on discovering new drug modalities from eukaryotic microbes, particularly fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, the company employs an integrated platform that combines genomics, artificial intelligence, and synthetic biology. This innovative Avatar-Rx platform utilizes high-throughput microbiology, data science, machine learning, genome engineering, and automation to explore the fungal biosphere for novel genetically encoded molecules with specific biological functions. By integrating chemoinformatic-assisted drug optimization and advanced chemical synthesis with biotransformation, LifeMine Therapeutics aims to advance a pipeline of new medicines into development.

Toast, Inc. is a restaurant technology company that provides a comprehensive point-of-sale and management platform tailored for the food service and hospitality industry. Founded in 2011 and headquartered in Boston, Massachusetts, with additional offices in Portland, Oregon; Omaha, Nebraska; and Dublin, Ireland, Toast serves a diverse range of establishments, including restaurants, bakeries, cafés, bars, nightclubs, and pizzerias. Its cloud-based system features advanced capabilities such as tableside ordering, online ordering, real-time enterprise reporting, and labor management, all designed for ease of use. By integrating payment processing with its software services, Toast supports around 120,000 restaurant locations across the United States, processing significant transaction volumes annually. The company generates revenue through software subscription fees, transaction fees, and other services, positioning itself as a key player in the restaurant technology sector.

Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutic antibodies for solid tumors and hematological malignancies. Founded in 2014 and based in Cambridge, Massachusetts, the company utilizes its proprietary StitchMabs and common light-chain platforms to identify and develop innovative antibody therapeutics. Its lead product candidate, CTX-471, is an agonistic monoclonal antibody targeting CD137, currently undergoing Phase I clinical trials. Another significant candidate, CTX-009, is a bispecific antibody that inhibits DLL4-mediated Notch signaling and VEGF-A signaling, and has completed a Phase 1 dose escalation study. Additionally, CTX-8371, another bispecific antibody targeting PD-1 and PD-L1, is in the IND-enabling stage. Compass Therapeutics aims to engage the immune system effectively to advance its therapeutic offerings.

Evelo Biosciences is a biotechnology company focused on discovering and developing oral biologics known as monoclonal microbials for the treatment of inflammatory diseases and cancer. These innovative medicines are designed to modulate systemic immunology through direct interactions with human cells in the gut, offering potential applications across a wide range of conditions, including autoimmune and neuroinflammatory diseases, as well as various cancers. Evelo's lead product, EDP1815, is currently undergoing clinical trials for psoriasis and atopic dermatitis, while other candidates are in preclinical stages for conditions such as psoriatic arthritis, asthma, and colorectal cancer. Founded in 2014 and based in Cambridge, Massachusetts, Evelo aims to enhance the efficiency and effectiveness of drug discovery by leveraging naturally occurring microbial entities with defined therapeutic effects.

ClassPass Inc. is an online fitness class booking service that offers a subscription model granting access to a wide network of boutique fitness studios and gyms. Established in 2011 and based in New York, the company connects members to over 25,000 partner locations globally, providing a diverse range of fitness options, including yoga, cycling, Pilates, boxing, and more. ClassPass enhances the member experience by utilizing machine learning to recommend classes from its extensive catalog, which features more than 5 million class offerings monthly. Additionally, the platform supports fitness studios by helping them manage excess inventory and attract new customers, ultimately fostering growth within the fitness industry.

Bowery Farming Inc. is a modern farming company based in New York that specializes in post-organic produce, offering products such as baby kale, lettuce, arugula, and basil. Founded in 2014, Bowery aims to revolutionize agriculture by using technology to create ideal indoor farming conditions. Its proprietary software, BoweryOS, integrates vision systems, automation, and machine learning to monitor and optimize plant growth continuously. This controlled environment allows Bowery to produce food using zero pesticides and 95% less water, achieving over 100 times the productivity of traditional farming on the same land footprint. Bowery's produce is available in select grocery stores, including Whole Foods and Foragers, and is featured on the menus of renowned restaurants in New York.

Cockroach Labs, Inc. is a developer of open-source database software, primarily known for its distributed SQL database, CockroachDB. Founded in 2015 and headquartered in New York, with an additional office in Cambridge, Massachusetts, the company provides a cloud-native platform designed for modern application development. CockroachDB allows organizations to build scalable applications that can withstand various types of failures, including those at the disk, machine, rack, and datacenter levels, with minimal disruption and no manual intervention. The database supports strongly consistent ACID transactions and offers an SQL API for data manipulation and querying. Its software is utilized by a diverse range of customers, from startups to Fortune 500 companies, across various industries, providing enterprise-grade disaster recovery services and enabling rapid development without compromising on consistency.

Clover Health Inc. is a health insurance provider focused on offering Medicare Advantage plans to senior citizens, primarily based in New Jersey. Founded in 2014 and headquartered in San Francisco, the company also operates in several other states, including Arizona, Georgia, Pennsylvania, South Carolina, Tennessee, and Texas. Clover Health employs a Preferred Provider Organization (PPO) platform designed to enhance the quality of care for its members and their physicians. Utilizing patient-centered analytics and a dedicated care management team, Clover aims to identify potential health risks and deliver preventive care, which helps in reducing avoidable healthcare expenditures and managing chronic diseases. The company’s proprietary software platform, Clover Assistant, equips physicians with personalized insights for early detection and management of chronic conditions. Clover Health operates mainly through its Insurance segment, which includes its PPO and Health Maintenance Organization (HMO) plans, while also participating in the ACO REACH Model in its Non-Insurance segment.